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Review Article

Comparison of turnaround times (TAT) in Pathology
laboratories from developed and developing countries,
and its impact on treatment
Jeyapal Rishikha, Naidu Shajeedth S, Shetty Jeevan K, Naik Venkatesh R*
Email: venkatesh@perdanauniversity.edu.my

Abstract
The timeliness of histopathology reports is one of the most crucial aspects of patient care. Turnaround Time
(TAT) is one such parameter that is often considered when performing tests in pathology labs. Simply put, it
is the time interval between the day a specimen is accessed in the lab, to the day the final report is signed out.
Aims: This study aimed to compare the turnaround times in histopathology labs of developed and developing
countries and to explore the impact of turnaround times on medical treatment. Materials and Methods: Our
current review on retrieved articles from databases such as PubMed, EBSCO host and MEDLINE. This study
includes the articles published between the years 2000 to 2020. The articles were searched by using keywords
such as “turnaround time (TAT)” “developing countries”, “developed countries”, “mean TAT” and “impact of
TAT on medical treatment”. Results: The search fetched 30 articles, among which 11 were relevant to our study.
Conclusion: TAT was higher in developing countries compared to developed countries. Lower TAT in developed
countries was linked to better infrastructure, resources and technological advancement. Shorter TAT enables
early diagnosis and treatment, which in turn helped to achieve better health care outcomes in the developed
countries compared to developing countries.
Key words: Turnaround Time, Mean Turnaround Time, Developed countries, Developing countries, and Impact
on treatment.

Introduction
Pathology is the study of tissues, cells and body fluid
samples to diagnose or predict the progression of
various diseases.1 It provides diagnostic information
to the clinicians and the patients. Pathology addresses
four components of disease: cause, mechanisms of
development, structural alterations of cells and the
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consequences of changes.2 Pathologists use gross,
microscopic, immunologic, genetic and molecular
modalities to ascertain the presence of disease and
very often work closely with surgeons, radiologists,
oncologists etc.3
Pathology tissue samples are examined in
histopathology laboratories. The pathology
laboratory specimens require tissue preparation,
which is then treated and analyzed using techniques
appropriate to the type of tissue and the investigation
required. The testing of body tissues varies from pap
smears to biopsies, and for body fluids, it includes
testing blood and urine samples.4 The results of these
tests usually help doctors diagnose and treat patients
promptly. These tests need to be done accurately
in a given period of time so that the patients can
be diagnosed and an appropriate treatment plan is
designed. Any unjustified complications that could
result in morbidity due to delayed reports can be
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avoided. Therefore, the timeliness of reports is one
of the most crucial aspects of patient care.
Turnaround Time (TAT) is one such parameter
that is often considered when performing tests in
pathology labs. Simply put, it is the time interval
between the day a specimen is accessed in the lab
to the day the final report is signed out.5 It is a
significant quality indicator for surgical pathology
laboratories. Many factors like tissue type, number
of slides, decalcification, immunohistochemistry
and consultation with other pathologists will affect
the TAT.6 According to the College of American
Pathologists, the expected TAT for most routine
cases (90%) is less than two days. However, based
on the study conducted in 2014-15, an average of
about a quarter (24%) of routine surgical pathology
testing does not meet the College of American
Pathologists’ standard TAT recommendation.7 This
is because different labs across the world have varied
access to resources, and the type of healthcare
system also varies from one country to another.
The International Monetary Fund (IMF) classifies
countries as developed or developing based on several
factors, including per capita income and Gross
Domestic Product (GDP).8 Both of these factors
contribute to the availability of funds that can be
used to develop a country. Hence, the advancement
of the health care sector also depends on these
factors. As a result, pathology laboratories will also
be affected by the growth of the health care sector.
Therefore, TAT in histopathology laboratories relies
significantly on the technological advancements in
the country’s health care sector.
In contrast, developing countries tend to have poor
infrastructure and inadequate access to various
services. Technological advancements can be
slow, and hence the use of modern equipment and
machines can be undermined.9 As a consequence,
lack of technology will lead to longer TAT. This
can have a severe impact on the quality of health
care services provided. On the other hand, developed
countries, with their bounty of resources, both
economically and technologically, have better access
to health care facilities and medical management.
These differences in the availability of resources
and access to equipment will lead to shorter TAT

in developed countries. We have designed this study
to provide comprehensive information about the gap
between the TAT in these countries and its impact
on health care. This review intends to compare the
TAT in pathology labs of developed and developing
countries and assess the effect of the TAT on
medical care.
Materials and methods
Literature Search Strategy
A systematic review was performed to explore the
TAT in pathology laboratories of developed and
developed countries and to explore the impact of
TAT on medical care. Our literature search was based
on a keyword-based search, database selection and
limiting the search results and number of articles
extracted according to the inclusion and exclusion
criteria. Most of the articles were collected from our
university library databases and were selected based
on the above criteria. We have used the databases such
as PubMed, EBSCO host and MEDLINE. Some free
online journals that fulfilled our inclusion criteria
were also included in the study. From the original
questions, key phrases and Boolean characters used
in the search were ‘Turnaround time in Pathology
labs’, ‘Turnaround time in developed countries’,
‘Turnaround time in developing countries’ and
‘Median turnaround time’.
Inclusion and Exclusion Criteria
The inclusion criteria were articles from developed
and developing countries and the TAT in pathology
labs for the respective countries. We also included
articles dating between the years 2000 to 2020. A
poor technological setup in labs before these years
will significantly impact our comparisons. Hence,
we decided to limit our time frame for articles to no
earlier than the year 2000. The databases included
PubMed, EBSCO host and MEDLINE. Only articles
written in English with full text were included in
our study, and articles from other languages were
excluded. Studies reported from both educational
institutions and standalone laboratories have been
included as available.
Process of selecting relevant studies
All the articles retrieved through search criteria
were reviewed for the study scope by closely
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examining the objectives of the study. This search
strategy identified 11 articles based on our inclusionexclusion criteria. Figure 1 depicts the process of

identifying, screening and choosing the eligible
articles suitable using the PRISMA guidelines.

Fig 1:. PRISMA flow diagram, including database searches, the number of abstracts screened, and the full texts
retrieved.

Results
Developed Countries

Table 1: Median TAT in pathology labs in developed
countries.

Table 1 shows the median TAT in pathology
laboratories in developed countries. The countries
we have chosen to be included in this comparison are
the United States of America, Canada and Australia.
Among the selected countries, Australia shows
significant results with a TAT of one day10, which is
the shortest time among the selected countries. The
United States of America and Canada show results
of TAT from one to three days.11
38
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Country
USA (Volmar et al., 2015)
Canada (Volmar et al., 2015)
Australia (Akinfenwa et al., 2017)

Turnaround time
(days)
1-3
1-3
1

Among developed countries, TAT for Large and
Complex Specimens in surgical pathology was
studied.11 This was a Q-probe study that was
conducted by the College of American Pathologists

Manipal Journal of Medical Sciences | June 2021 | Volume 6 | Issue 1

3

Manipal Journal of Medical Sciences, Vol. 6 [2021], Iss. 1, Art. 7
Rishikha J et al: Turnaround times in developed and developing countries and its impact on treatment.

among 56 institutions involving three countries (51
in the USA (Table 1), four in Canada (Table 1) and
one in Saudi Arabia (Table 2)). The median TAT
reported for these countries was 2.72 days.
Developing Countries
Table 2 shows the median TAT in pathology
laboratories in developing countries. The countries
that were chosen to be included in this comparison
were Rwanda, Botswana, Myanmar, Malawi and
Saudi Arabia. Among the selected list of developing
countries, the TAT in Malawi is significantly the
longest. However, the TAT of Saudi Arabia is also
notable as it is between one to three days, being
comparable to the TAT of developed countries such
as Australia, the USA and Canada.11
Table 2: Median TAT in pathology labs in developing
countries.
Turnaround time
(days)
Rwanda (Muvugabigwi et al.,2018)
30
Botswana (Martei et al., 2018)
57.5
Myanmar (Thiha et al., 2017)
49
Malawi (Masamba et al., 2017)
71
Saudi Arabia (Volmar et al., 2015)
1-3
Country

A study was done aimed to inspect analytic TAT
in a histopathology laboratory in Nigeria.10 They
searched records of 1440 batches of specimens over
a period of 5 years in a Nigerian teaching hospital.
A median analytic TAT of two days was obtained. It
was observed that the Nigerian hospital had a 40.7%
sign-out rate on day-1, which was slower than the
day-1 TAT observed in Australia (Table 1).
A study was conducted to quantify TAT for breast
cancer specimens that were processed by the National
Health Laboratory and Diagnofirm Laboratory
in Gaborone, Botswana.12 A total of 219 surgical
specimens were analyzed, and a median TAT of 57.5
days was obtained.
In Rwanda, a study was conducted on pathology lab’s
TAT by comparing different modes of transport.13
Tissue blocks and slides were prepared in Butaro
and then physically transported to Brigham and
Women’s Hospital in Boston, MA, for evaluation and
diagnosis. A median TAT of 30 days was observed
among tissue blocks of 2695 patient samples.
However, when static images of slides prepared in

Butaro by histo-technicians were uploaded to the
case-sharing software/platform ‘iPath’, the median
TAT was reduced to 14 days.
A study in Myanmar collaborated with the National
AIDS program, where an integrated HIV care
program implemented early infant diagnosis
through Anti-Retroviral Therapy (ART) centers
across ten cities in five states of Myanmar. Here,
a median TAT from sample collection to reporting
was observed to be around seven weeks (49 days).14
A study conducted at Queen Elizabeth’s Central
hospital in Malawi showed that a median TAT of
31 days was observed for 544 suspected cancer
patients.15 It was observed that a higher median TAT
was observed here when compared to other African
and high-income countries.
Discussion
Based on the results shown in Table 1 and Table 2,
the median TAT, in general, is found to be longer in
developing countries when compared to developed
countries. This is because TAT is affected by the
advancements seen in technology within a particular
country. Developed countries have more access
to funds that can be used to enhance laboratory
equipment which will, in turn, decrease TAT and
increase efficiency. However, developing countries do
not have available funds present to be used to buy the
equipment of current standards in their pathology
laboratories and depend heavily on equipped labs
that are often overloaded with samples. This also
leads to an increase in TAT. The usage of automated
instruments in laboratory testing in developed
countries also aids in shortening TAT. Furthermore,
the affordability to procure automated instruments
provides an avenue to reduce manual labour in
pathology labs which in turn significantly reduced
the TAT. Therefore, as technological advancements
are not as rapid in developing countries, TAT is
longer in pathology labs.
Tissue processing for histopathological examination
is a tedious and time-consuming process. A study
done in 2007 reported that various automation
done in different testing stages would greatly
help reduce the TAT. Procedures like fixation
and processing can be automated to save up to 24
hours, and the slides are ready for viewing by the
second day.16 Nowadays, tissue processing using
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microwave techniques also speeds up the time taken
for processing. Until recently, automation in the
histopathology laboratories was only restricted to
tissue processing and slide preparations. Recently
studies have proposed the use of “Signal Processing
Technology” to screen the slides automatically.17
In an editorial article in Nature Biomedical
Engineering journal exciting new technologies have
been described like “soaking whole tissue samples
with fluorescent dyes, whose surface-emission
under ultraviolet illumination can then be visualized
within minutes through a camera with standard
optics.” “Performing optical ‘sections’ the sample,
hence enabling volumetric imaging by stacking
virtual slices (each taking less than 10 minutes
to image)” and “Tissue staining circumvented by
using spectroscopic techniques that take advantage
of endogenous contrast generated from tissue
components”.18
A recent study proposed mathematical modelling
to predict a reduction in TAT in a histopathology
laboratory. A “mixed-integer linear program”
(MILP) was used to predict specific times of three
days for particular activities, for example, tissue
processing. They found that it helped save up to 25%
decrease in TAT and spread the work equally over
the day.19 In this study, TAT for both small biopsies
and large specimens was included. However, they
were not deemed suitable for separation due to a
lack of literary evidence to support such practice.
A recent study reported TAT from laboratories
with 19 articles. Among those, most of them were
looking at Chemical pathology laboratories’ TAT
by exploring the time taken to get reports if serum,
blood samples are given but not looking at the tissue
samples.20
As for developing countries such as Rwanda, higher
than ideal TAT was caused by the need for physical
transport to diagnostic centers.13 This increased
the TAT because of the impact imposed by these
logistic challenges. The same study was carried
out in a different mode. In this, static images of
slides prepared in Butaro by histo-technicians were
uploaded to the case-sharing software/platform
‘iPath’. This eliminated the logistic challenges
caused by physically transporting the slides. Hence,
the TAT was significantly reduced (median TAT was
14 days).13 Investments in shipment demonstrated a
40
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more consistent means for transport and reception
of samples. Moreover, the need to transport samples
to other locations outside the country for diagnostic
purposes significantly increased the TAT in this
study.13 The availability of in-country processing
also impacts TAT as a developing country like
Rwanda will face challenges in moving samples to
a developed country13 such as the United States.
Therefore, the availability of funds to the developed
countries helped improve their infrastructure in
terms of logistics which had a significant impact on
TAT.
For easier tracking, TAT can be divided into three
phases: 1) Pre-analytical 2) Analytical and 3) Postanalytical.21, 22 The pre-analytical phase is where
most of the delays can be observed, owing to a
longer TAT.21 It also explains the large TAT in
developing countries, as most of these steps must be
done manually.
Table 3: Phases in analyzing laboratory TAT.
Phases

Tasks
Transport to a laboratory,
sample receiving and
Pre-analytical phase
labelling, tissue processing,
bar code scanning, specimen
loading.
Analysis of the specimen,
Analytical phase
interpretation and finalizing
the reports.
Proofreading, verification,
Post- analytical phase
dispatch of the results.

TAT impacts medical care because shorter TAT
helps in early diagnosis and treatment for the illness.
It is evident that delays in diagnosis can severely
impact patient outcome because of unnecessary
complications. In an 11-hospital based study
conducted in the emergency department [ED]
settings, the average length of stay in the ED
correlated significantly with the percentage of total
laboratory outlier results and, to a lesser extent,
the TAT. The authors recommended that a more
appropriate method of benchmarking might be to
aggressively set clinically driven TAT targets and
assess performance as the percentage of results
achieving this goal.23 It is essential to make sure that
laboratory data is obtained fast and is also accurate.
This will help the medical professionals to institute
an appropriate treatment, thereby increasing the
efficiency of clinicians. This also leads to an increase
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in the quality of care and patient satisfaction.24
However, it has to be noted that adequate clinical
information (CI) is necessary for timely and error-free
reporting of a specimen in surgical histopathology.
A short-focused and concise CI is associated with a
shorter TAT. Long and detailed CI is often seen with
a complex surgical specimen that requires a longer
time to report. Factors like specimen type, special
staining, and the need for the use of multiple special
stains and diagnosis of malignancy also affect
TAT.25 It is widely accepted that those teaching
hospitals by nature of their work, including the
process of teaching in the laboratory activity, would
naturally have longer TAT compared to laboratories
that are only service-oriented. Studies have stated
that longer TAT is seen in teaching hospitals and
big institutions.10 In this study, the author concluded
that there is an increasing disparity between
developed and developing countries in terms of
histopathology practice. They attributed this to
challenges such as human resources, finances, lack
of facilities, lag in technological advancement, lack
of quality assurance programs and increasing cases
of litigation among others.26
Conclusion
TAT varies according to different conditions like
sample size, participants’ involvement, staffing
practices, access to resources etc. It is also different
in various medical departments. Since pathology
has many sub-divisions, it is challenging to achieve
precise TAT measurements and compare them as
they have been calculated from widely different
conditions and samples. So, what exactly is a suitable
TAT? Though the College of American Pathologists
has recommended that report completion be done
within two working days, this checklist (ANP.12150)
was deleted on July 10, 2011.11 It was also suggested
by the Association of Directors of Anatomic and
Surgical Pathology (ADASP) in the 1990s that
80% of routine biopsies be completed within two
working days and a written report to be made
available within three working days. The ADASP
has now denoted that the acceptable TAT should be
selected based on present-day literature and that it
can also vary depending on the complexity of the
case.11 Hence, an appropriate TAT is something that
an individual institution should decide, keeping in
mind that timeliness and accuracy are the pillars of
quality management in the health care industry.11

Limitations
The study’s limitations include small sample size,
wide variation on what is accepted as “Turnaround
Time”, looking at only articles published in the
English language. Broadly grouping the countries
into developed and developing countries and not
taking healthcare infrastructure expenditure by
different countries.
References
1. Pathology Clinical Services for Patients
[Internet]. Nyu.edu. [cited 2021 Apr
28]. Available from: https://med.nyu.edu/
pathology/patient-care/patients/practicepathology.
2. Kumar V, Abbas AK, Fausto N, Aster JC.
Robbins and cotran pathologic basis of disease,
professional edition E-book. 9th ed. Saunders;
2014.
3. Cap.org. [cited 2021 Apr 28]. Available from:
https://www.cap.org/member-resources/
articles/what-is-pathology.
4. What is pathology? [Internet]. Com.au. 2021
[cited 2021 Apr 28]. Available from: https://
knowpathology.com.au/what-is-pathology/
5. B S, A S. Turnaround Time of Surgical
Pathology Reports in a tertiary care teaching
hospital, 2019. PJMHS. 13(2).
6. Patel S, Smith JB, Kurbatova E, Guarner J.
Factors that impact turnaround time of surgical
pathology specimens in an academic institution.
Hum Pathol. 2012;43(9):1501–5.
7. Alshieban S, Al-Surimi K. Reducing turnaround
time of surgical pathology reports in pathology
and laboratory medicine departments. BMJ Qual
Improv Rep. 2015;4(1):u209223.w3773.
8. Nielsen L, LNielsen@imf.org. Classifications of
Countries Based on their Level of Development:
How it is Done and How it Could Be Done. IMF
Work Pap. 2011;11(31):1.
9. No title [Internet]. Study.com. [cited 2021
Apr 28]. Available from: https://study.com/
academy/lesson/healthcare-in-developing-vsdeveloped-countries.html
10. Yusuf I, Atanda A, Haruna M. Perceived and
real histopathology turnaround time: A teaching
hospital experience. Niger J Surg. 2017;23(2):98.
11. Volmar KE, Idowu MO, Souers RJ, Karcher
DS, Nakhleh RE. Turnaround time for large
or complex specimens in surgical pathology: a

Manipal Journal of Medical Sciences | June 2021 | Volume 6 | Issue 1

https://impressions.manipal.edu/mjms/vol6/iss1/7

41

6

Jeyapal et al.: Comparison of turnaround times (TAT) in Pathology laboratories fr
Rishikha J et al: Turnaround times in developed and developing countries and its impact on treatment.

12.

13.

14.

15.

16.
17.

18.
19.

College of American Pathologists Q-Probes
study of 56 institutions. Arch Pathol Lab Med.
2015;139(2):171–7.
Martei YM, Narasimhamurthy M, Prabhakar P,
Hutson J, Setlhako DI, Chiyapo S, et al. Breast
cancer pathology turnaround time in Botswana.
J Glob Oncol. 2018;4(4):1–7.
Muvugabigwi G, Nshimiyimana I, Greenberg L,
Hakizimana E, Ruhangaza D, Benewe O, et al.
Decreasing histology turnaround time through
stepwise innovation and capacity building in
Rwanda. J Glob Oncol. 2018;4(4):1–6.
Thiha S, Shewade HD, Philip S, Aung TK, Kyaw
NTT, Oo MM, et al. Early infant diagnosis of HIV
in Myanmar: call for innovative interventions to
improve uptake and reduce turnaround time.
Glob Health Action. 2017;10(1):1319616.
Masamba LPL, Mtonga PE, Kalilani Phiri L,
Bychkovsky BL. Cancer pathology turnaround
time at Queen Elizabeth Central Hospital, the
largest referral center in Malawi for oncology
patients. J Glob Oncol. 2017;3(6):734–9.
Morales AR, Nassiri M. Automation of the
histology laboratory. Lab Med. 2007;38(7):405–
10.
McCann MT, Ozolek JA, Castro CA, Parvin
B, Kovacevic J. Automated Histology Analysis:
Opportunities for signal processing. IEEE
Signal Process Mag. 2015;32(1):78–87.
Histopathology is ripe for automation. Nat
Biomed Eng. 2017;1(12):925.
Leeftink AG, Boucherie RJ, Hans EW,
Verdaasdonk MAM, Vliegen IMH, van Diest
PJ. Predicting turnaround time reductions

20.

21.

22.

23.

24.
25.

26.

of the diagnostic track in the histopathology
laboratory using mathematical modelling. J Clin
Pathol. 2016;69(9):793–800.
Breil B, Fritz F, Thiemann V, Dugas M. Mapping
turnaround times (TAT) to a generic timeline:
a systematic review of TAT definitions in
clinical domains. BMC Med Inform Decis Mak.
2011;11(1):34.
Chung H-J, Lee W, Chun S, Park H-I, Min W-K.
Analysis of turnaround time by subdividing
three phases for outpatient chemistry specimens.
Ann Clin Lab Sci. 2009 Spring;39(2):144–9.
K AV, K S, G A, S KD. Analysis of quality
assurance: a novel step in fixing the turn-around
time of surgical pathology reports as a part of
quality management system. IP J Diagn Pathol
Oncol. 2017;2(4).
Holland LL, Smith LL, Blick KE. Reducing
laboratory turnaround time outliers can reduce
emergency department patient length of
stay: an 11-hospital study. Am J Clin Pathol.
2005;124(5):672–4.
Dey B, Bharti JN, Chakraborty M. Laboratory
turnaround time. Int J Health Sci Res. 2013;3(5).
Ali SMH, Kathia UM, Gondal MUM, ZilE-Ali A, Khan H, Riaz S. Impact of Clinical
information on the turnaround time in surgical
histopathology: A retrospective study. Cureus.
2018;10(5):e2596.
Uchendu OJ. Challenges of practicing
histopathology in a developing country: the
Nigerian perspective. Annals of Biomedical
Sciences. 2013;12:59–65.

Copyright: ©2021 by the authors. This article is an open access article distributed under the terms and conditions of the Creative
Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/)
42

Published by Impressions@MAHE, 2021

Manipal Journal of Medical Sciences | June 2021 | Volume 6 | Issue 1

7

